Shin Nippon Biomedical Laboratories, Ltd. (FRA:YB3)
10.00
+0.50 (5.26%)
At close: Nov 28, 2025
Shin Nippon Biomedical Laboratories Employees
Shin Nippon Biomedical Laboratories had 1,436 employees as of March 31, 2025. The number of employees increased by 95 or 7.08% compared to the previous year.
Employees
1,436
Change (1Y)
95
Growth (1Y)
7.08%
Revenue / Employee
€130,423
Profits / Employee
€17,507
Market Cap
409.37M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1,436 | 95 | 7.08% |
| Mar 31, 2024 | 1,341 | 133 | 11.01% |
| Mar 31, 2023 | 1,208 | 214 | 21.53% |
| Mar 31, 2022 | 994 | 8 | 0.81% |
| Mar 31, 2021 | 986 | 1 | 0.10% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Aktiengesellschaft | 318,000 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 103,000 |
| Deutsche Bank Aktiengesellschaft | 89,753 |